Key result
Aspirin inhibits the synthesis of both prostacyclin and thromboxane A2 but is more active in blocking TXA2 formation, suggesting a potential anti-thrombotic effect.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Supports aspirin's TXA2 selectivity as mechanistic basis for anti-thrombotic use; leaves open prospective outcome trials.
Moncada et al. (2009) studied this question. Aspirin inhibits the synthesis of both prostacyclin and thromboxane A2 but is more active in blocking TXA2 formation, suggesting a potential anti-thrombotic effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: